Informazioni
Dr Mubarak Almansour is a highly qualified Consultant Medical Oncologist and Associate Professor, recognised for their expertise in the diagnosis and management of complex cancer cases. With a patient-centred approach to care, Dr Almansour combines clinical excellence with a strong academic background, ensuring that patients receive treatment based on the latest medical evidence. They are dedicated to providing comprehensive oncology care, guiding patients through their treatment journeys with compassion and professional rigour.
Dr Almansour’s extensive medical training was completed at world-renowned institutions in North America. After obtaining their medical degree from King Abdulaziz University, they pursued postgraduate training at the University of British Columbia in Canada. There, they completed a residency in Internal Medicine followed by two specialised fellowships at the British Columbia Cancer Agency: one in Medical Oncology and a second sub-specialty fellowship dedicated to Lymphoma. They hold quadruple board certifications, having achieved the American Board and Canadian Board certifications in both Internal Medicine and Medical Oncology.
In addition to their clinical practice, Dr Almansour is an active leader in the medical community and a key contributor to oncology research. They have played a pivotal role in establishing international conferences and serve on scientific committees dedicated to advancing cancer treatment. Their clinical focus encompasses a broad range of adult malignancies, with specific sub-specialty interest in lymphoid malignancies and genitourinary tumours.
Dr Almansour’s extensive medical training was completed at world-renowned institutions in North America. After obtaining their medical degree from King Abdulaziz University, they pursued postgraduate training at the University of British Columbia in Canada. There, they completed a residency in Internal Medicine followed by two specialised fellowships at the British Columbia Cancer Agency: one in Medical Oncology and a second sub-specialty fellowship dedicated to Lymphoma. They hold quadruple board certifications, having achieved the American Board and Canadian Board certifications in both Internal Medicine and Medical Oncology.
In addition to their clinical practice, Dr Almansour is an active leader in the medical community and a key contributor to oncology research. They have played a pivotal role in establishing international conferences and serve on scientific committees dedicated to advancing cancer treatment. Their clinical focus encompasses a broad range of adult malignancies, with specific sub-specialty interest in lymphoid malignancies and genitourinary tumours.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Mubarak Almansour
Istruzione e formazione
-
2011–2017 MD · Medicine and Surgery
-
2017–2021 Residency · Oncologia
-
2021–2022 Fellowship · Subspecialty training
Carriera e incarichi
-
2021-09–2022-08 Junior consultant
Licenze e assicurazione
Licenze mediche
SA — Organización Médica Colegial de España (OMC)
Certificazioni di specializzazione
European Board of Oncologia
Assicurazione responsabilità professionale:
Generali Healthcare · 3,000,000 EUR copertura · No claims on file
Procedure eseguite
| Procedura | Codice | Conteggio totale |
|---|---|---|
| GP consultation | 99213 | 1,636 |
| Annual physical exam | 99395 | 1,442 |
| Vaccination administration | 90471 | 1,370 |
| Minor procedure (skin) | 17110 | 1,605 |
Servizi e prezzi
| Servizio | Durata | Modalità | Prezzo |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 60 min | in_clinic | 630.00 EUR |
| Minor procedure (skin) | 90 min | in_clinic | 720.00 EUR |
Studio, team e in pratica
Video
Ricerca e pubblicazioni
indice h: 17 · i10: 10
-
European registry analysis of Oncologia outcomes
DOI: 10.6789/euroclin.2025.0 · PMID: 32497645 · citato da 84
-
Outcomes of Oncologia in adults — a multi-centre cohort
DOI: 10.2529/euroclin.2024.1 · PMID: 37582222 · citato da 6
-
European registry analysis of Oncologia outcomes
DOI: 10.7214/euroclin.2023.2 · PMID: 36115057 · citato da 144
-
Outcomes of Oncologia in adults — a multi-centre cohort
DOI: 10.5013/euroclin.2022.3 · PMID: 31578989 · citato da 42
Conferenze su invito
- Practical updates in Oncologia European Annual Congress (Oncologia) · Vienna · 2024 · invited
- Single-centre experience in Oncologia National Society Meeting · Riyadh · 2023 · oral abstract
Premi e affiliazioni
Premi
- 🏆 Top-rated Oncologia — Riyadh · EuroClinics Patient Choice · 2025 · regional
Iscrizioni a società
- WONCA Europe — Family Doctors — Member · Dal 2022
- national college of family doctors — Member · Dal 2022
- European Union of Medical Specialists (UEMS) — Member · Dal 2022
Articoli di questo medico
- Patient education Patient guide to Oncologia
- Awareness When should you see a oncologia?
Per pazienti internazionali
- Coordinatore
- Patient liaison · mubarak.almansour@euroclinics.example
Posizione
1 tagRecensioni dei pazienti
Condividi la tua esperienza — aiuta altri pazienti a trovare il medico giusto. Scrivi una recensione →
Recensioni recenti
-
★★★★★ ✓ Verificato Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verificato Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verificato Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.